A device and method for injecting liquid embolic agents utilizing a plug and push technique, The device/catheter has at least one side hole or an externally swellable region which creates a plug upstream of the distalmost portion of the catheter and thereby ameliorates the suboptimal outcomes associated with creating a plug upstream of a distal end hole via injecting embolic agents only at the distalmost portion of the catheter. The catheter can include a flow restricting structure to initially block flow of the liquid embolic agent out the distal end hole and direct flow of the liquid embolic agent through the one or more side holes.

An adhesive deliver apparatus includes: a holder; an adhesive tube, containing an adhesive fluid and positioned inside the holder, wherein the adhesive tube comprises a nozzle and a nozzle seal formed on the nozzle; a support tube comprising a proximal end and a distal end; a connector, arranged to operably connect with the proximal end of the support tube; and an inner tube, positioned within the support tube and comprising an inlet end connected with the connector and an outlet end approximating to the distal end of the support tube. When the connector is inserted into the holder, a portion of the connector would break through the nozzle seal. When the holder is pressed, the adhesive fluid will be squeezed out from the adhesive tube and transmitted through the inner tube from the inlet end to the outlet end.

In the present disclosure, embodiments of dual-stage syringes are disclosed along with delivery systems incorporating the dual-stage syringes. Embodiments of the dual-stage syringes described herein include sleeved dual-stage syringes, turn-key dual-stage syringes and dual-stage syringes including one or more one-way valves.

In the present disclosure, embodiments of microbead containment systems and containment methods are disclosed. The microbead containment system may include a microsphere container, which includes walls that define a containment space in the microsphere container, and microspheres within the containment space. The walls may include at least one magnetic component configured to produce a magnetic field within the containment space. The microspheres may include a diamagnetic material. The method of containing radioactive microspheres may include loading a plurality of microspheres comprising a diamagnetic material in a container comprising one or more magnetic components. The microspheres contained in the microsphere container interact with the magnetic field in a manner that prevents direct contact of the microspheres and the microsphere container.

In the present disclosure, embodiments of flaring tip microcatheters, methods of deploying flaring tip microcatheters, and embolization treatment methods are disclosed. The flaring tip microcatheter may include a hollow shaft having a shaft lumen defined therein, a core disposed within the shaft lumen, and a tip comprising at least two petals affixed to a distal end of the core, the at least two petals comprising at least two wires wherein the core is hollow and defines a core lumen. The at least two wires may be configured to pull the at least two petals to form a flared configuration of the tip. The flared configuration of the tip may allow for laminar flow of a therapeutic agent distally from the tip.

A catheter assembly configured for use with a male luer is provided herein. The catheter assembly can comprise a catheter hub having an interior chamber and a valve located in the interior chamber. The valve can comprise a distal portion, a proximal portion, and a sidewall extending therebetween to define a valve interior. The valve can include a barrier layer having a concave shape that extends in the valve interior from the sidewall at the distal portion. The barrier layer can have at least one slit extending therethrough that is in a normally closed configuration to prevent a fluid from passing through the barrier layer. The catheter assembly can further comprise a sealing ring located circumferentially at a distal end of the valve distally to the barrier layer. The sealing ring can form a seal between the valve and the interior chamber at the distal end.

Endovascular drug delivery systems and methods are disclosed herein for delivering a therapeutic agent to the intracranial subarachnoid space of a patient, and/or deploying an endovascular drug delivery device distal portion in the intracranial subarachnoid space and a portion of the drug delivery device body in a dural venous sinus such that a therapeutic agent is delivered from the deployed drug delivery device into the intracranial subarachnoid space.

A pressure activated valve for controlling the flow of fluid through a medical device, the pressure activated valve comprises a housing including a lumen extending therethrough and a flow control membrane extending across the lumen of the housing to control the flow of fluid through the lumen by opening when a pressure threshold has been reached.

A catheter includes a detachable tip assembly that when detached from the catheter may be used to occlude a body lumen or vessel. The detachable distal tip assembly may include an inflatable balloon disposed over and secured to a tubular member. The inflatable balloon may be in fluid communication within an inflation lumen extending within the catheter body. Upon reaching a target site within a body lumen or vessel, the detachable distal tip assembly may be released from the distal end of the catheter upon inflation of the balloon to a predetermined size.

An innovative medical device that permits rapid, minimally invasive restoration of blood flow across a vascular blockage. A system allowing for lysis or removal of said blockage. Said device creates a temporary bypass using longitudinal structure configured for insertion into the blood vessel and adapted to deliver a side hole to a target area. The side hole defines a distal first segment and a proximal second segment with a lumen to allow blood flow therethrough to the distal end hole. In an alternate embodiment, a slidable outer sheath can cover the side hole to permit reversal of blood flow from the distal end hole to a proximal end hole located outside a patient's body by means of an aspiration controller. Alternate embodiments include an optional anchoring balloon, a macerating stent or wires, perforations for fluid delivery, and an backflow valve.